These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12497567)

  • 1. Effect of nondepleting anti-CD4 monoclonal antibody (Rib 5/2) plus donor antigen pretreatment in peripheral nerve allotransplantation.
    Doolabh VB; Tung TH; Wayne Flye M; Mackinnon SE
    Microsurgery; 2002; 22(8):329-34. PubMed ID: 12497567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
    Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
    Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
    Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
    Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
    Motoyama K; Arima T; Lehmann M; Flye MW
    Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against ICAM-1 and LFA-1 prolong nerve allograft survival.
    Nakao Y; MacKinnon SE; Hertl MC; Miyasaka M; Hunter DA; Mohanakumar T
    Muscle Nerve; 1995 Jan; 18(1):93-102. PubMed ID: 7800003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
    Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
    Scharpf J; Strome M; Siemionow M
    Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies.
    Genden EM; Mackinnon SE; Yu S; Flye MW
    Surgery; 1998 Aug; 124(2):448-56. PubMed ID: 9706170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K; Lehmann M; Flye MW
    Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats.
    Frazier J; Yu L; Rhee E; Shaw L; LaRossa D; Rostami A
    J Hand Surg Am; 1993 Jan; 18(1):100-6. PubMed ID: 8423292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.